Brian V. Slater (Chair/Moderator)


Kramer Levin Naftalis & Frankel LLP

Brian V. Slater, is Chair of the Life Sciences practice at Kramer Levin Naftalis & Frankel LLP.  Mr. Slater has over 25 years of patent litigation experience, including serving as first chair for clients including Forward Pharma, Gilead, Merck and Sanofi.  He has litigated biotechnology cases relating to fusion proteins, diagnostic kits and labeled nucleotides, and he counsels biologic/biosimilar clients on navigating the BPCIA litigation pathway.  He also has litigated numerous cases under the Hatch-Waxman Act, most recently helping Merck to win a judgment of patent infringement against Xellia Pharmaceuticals relating to a patent covering the life-saving, antifungal drug, Cancidas®.

Clients describe Mr. Slater as “a great decision maker” (IAM Patent 1000 2012) who is “admired for his strategic nous and calm demeanor in pressurized litigation scenarios” (IAM Patent 1000 2013) and is “brilliant on biosimilars.” (IAM Patent 1000 2014).